The positive association between CD27 and TIGIT, CD48 in the majority of cancers suggested a complete co-expressing landscape, and our data demonstrated that CD27 expression was strongly connected with various immunological checkpoints in varied immunocytes and unique T cells. Here, CD48 is linked to cancer.